Albert Ruzo
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery
- Renal and related cancers
Papers in
- Genetics 9
- Virus-based gene therapy research 6
-
- Genetic Neurodegenerative Diseases 3
- Co-authors
- Ali H. BrivanlouEric D. SiggiaIain MartynJakob J. MetzgerFred EtocAnna YoneyBrian D. BrownAlessia Baccarini
- Journals
- Development (3 papers)Molecular Therapy (2 papers)Diabetes (2 papers)Cell stem cell (1 paper)Nature Methods (1 paper)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Albert Ruzo
25 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 100
- Cancer Research 308
- Molecular Biology 1.4k
- Cell Biology 208
- Genetics 319
- Physiology 272
Countries citing papers authored by Albert Ruzo
This map shows the geographic impact of Albert Ruzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Ruzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Ruzo more than expected).
Fields of papers citing papers by Albert Ruzo
This network shows the impact of papers produced by Albert Ruzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Ruzo. The network helps show where Albert Ruzo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Albert Ruzo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 2 | |
| 3 | 2021 | 13 | |
| 4 | 2019 | 126 | |
| 5 | 2018 | 41 | |
| 6 | 2018 | 55 | |
| 7 | 2018 | 199 | |
| 8 | 2017 | 48 | |
| 9 | 2017 | 17 | |
| 10 | 2016 | 234 | |
| 11 | 2016 | 113 | |
| 12 | 2015 | 22 | |
| 13 | 2015 | 39 | |
| 14 | 2013 | 176 | |
| 15 | 2013 | 102 | |
| 16 | 2012 | 67 | |
| 17 | 2012 | 39 | |
| 18 | 2011 | 45 | |
| 19 | 2011 | 26 | |
| 20 | 2009 | 46 |
About Albert Ruzo
Albert Ruzo is a scholar working on Genetics, Cellular and Molecular Neuroscience, Developmental Neuroscience, Virology and Molecular Biology, having authored 25 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (8 papers), Virus-based gene therapy research (6 papers), CRISPR and Genetic Engineering (4 papers), RNA Interference and Gene Delivery (3 papers), Lysosomal Storage Disorders Research (3 papers), Genetic Neurodegenerative Diseases (3 papers), Pancreatic function and diabetes (3 papers) and Developmental Biology and Gene Regulation (3 papers). The work is most often cited by research in Cancer Research (308 citations), Molecular Biology (1.4k citations), Cell Biology (208 citations), Genetics (319 citations) and Physiology (272 citations). Albert Ruzo has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Ali H. Brivanlou, Eric D. Siggia, Iain Martyn, Jakob J. Metzger, Fred Etoc, Anna Yoney, Brian D. Brown, Alessia Baccarini, Navpreet Tung and Christoph Kirst. Their work appears in journals such as Development, Molecular Therapy, Diabetes, Cell stem cell and Nature Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.